Since 1999, nearly 841,000 people have died from a drug overdose, with synthetic opioids being responsible for 72.9% of these deaths. The opioid crisis has taken hundreds of thousands of lives over the past two decades, and with people becoming increasingly aware of the long-term consequences of using opioids, there has been increased interest in alternative pain relievers. Cannabis is one such alternative, and as more than 30 states have legalized it for either medical or recreational use, more people have been abandoning opioids and turning to the controversial plant for pain relief.
There were, and still are, many objections to legalizing cannabis, with one of them being that it would be a gateway to opioid use. However, a recent study has found just the opposite: states that legalize recreational cannabis markets see a decline in opioid-related emergency department (“ED”) visits…
NOTE TO INVESTORS: The latest news and updates relating to Sonoma Biologics Corp. are available in the company’s newsroom at https://cnw.fm/Sonoma
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.